These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3007760)

  • 1. N-substituent modulation of opiate agonist/antagonist activity in resolved 3-methyl-3-(m-hydroxyphenyl)piperidines.
    Cheng A; Uyeno E; Polgar W; Toll L; Lawson JA; DeGraw JI; Loew G; Camerman A; Camerman N
    J Med Chem; 1986 Apr; 29(4):531-7. PubMed ID: 3007760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
    Thomas JB; Mascarella SW; Rothman RB; Partilla JS; Xu H; McCullough KB; Dersch CM; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 May; 41(11):1980-90. PubMed ID: 9599247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probes for narcotic receptor mediated phenomena. 44. Synthesis of an N-substituted 4-hydroxy-5-(3-hydroxyphenyl)morphan with high affinity and selective μ-antagonist activity.
    Iyer MR; Lee YS; Deschamps JR; Dersch CM; Rothman RB; Jacobson AE; Rice KC
    Eur J Med Chem; 2012 Apr; 50():44-54. PubMed ID: 22341895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
    Thomas JB; Fall MJ; Cooper JB; Rothman RB; Mascarella SW; Xu H; Partilla JS; Dersch CM; McCullough KB; Cantrell BE; Zimmerman DM; Carroll FI
    J Med Chem; 1998 Dec; 41(26):5188-97. PubMed ID: 9857089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute configuration and conformation of the pure opioid antagonist (+)-2,9 alpha-dimethyl-5-(m-hydroxyphenyl)morphan.
    Froimowitz M; Pangborn W; Cody V
    Chirality; 1992; 4(6):377-83. PubMed ID: 1449951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
    Le Bourdonnec B; Goodman AJ; Michaut M; Ye HF; Graczyk TM; Belanger S; Herbertz T; Yap GP; DeHaven RN; Dolle RE
    J Med Chem; 2006 Dec; 49(25):7278-89. PubMed ID: 17149858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies of narcotic agonists and antagonists from quantum chemical calculations.
    Loew GH; Berkowitz DS; Burt SK
    NIDA Res Monogr; 1978; (22):278-316. PubMed ID: 213725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity studies of morphine fragments. I. 4-alkyl-4-(m-hydroxy-phenyl)-piperidines.
    Loew GH; Lawson JA; Uyeno ET; Toll L; Frenking G; Polgar W; Ma LY; Camerman N; Camerman A
    Mol Pharmacol; 1988 Sep; 34(3):363-76. PubMed ID: 2843751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of addition of a 2-methyl group to ethyl nipecotates (beta-meperidines) on receptor affinities and opiate agonist/antagonist activities.
    Lawson JA; Cheng A; DeGraw J; Frenking G; Uyeno E; Toll L; Loew GH
    J Med Chem; 1988 Oct; 31(10):2015-21. PubMed ID: 2845084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probes for narcotic receptor mediated phenomena. 34. Synthesis and structure-activity relationships of a potent mu-agonist delta-antagonist and an exceedingly potent antinociceptive in the enantiomeric C9-substituted 5-(3-hydroxyphenyl)-N-phenylethylmorphan series.
    Hiebel AC; Lee YS; Bilsky E; Giuvelis D; Deschamps JR; Parrish DA; Aceto MD; May EL; Harris LS; Coop A; Dersch CM; Partilla JS; Rothman RB; Cheng K; Jacobson AE; Rice KC
    J Med Chem; 2007 Aug; 50(16):3765-76. PubMed ID: 17625813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.
    Zimmerman DM; Leander JD; Cantrell BE; Reel JK; Snoddy J; Mendelsohn LG; Johnson BG; Mitch CH
    J Med Chem; 1993 Oct; 36(20):2833-41. PubMed ID: 8410998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity studies of a series of 4-(m-OH phenyl) piperidines.
    Loew G; Lawson J; Toll L; Uyeno E; Frenking G; Polgar W
    NIDA Res Monogr; 1986; 75():49-52. PubMed ID: 3123966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel phenylpiperidine opioid antagonists and partial agonists: effects on fluid consumption.
    Leander JD; Hart JC; Lochner MA; Hynes MD; Zimmerman DM
    Eur J Pharmacol; 1982 Jul; 81(2):185-92. PubMed ID: 6288403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantum chemical studies of molecular features and receptor interactions that modulate opiate agonist and antagonist activity.
    Burt SK; Loew GH; Hashimoto GM
    Ann N Y Acad Sci; 1981; 367():219-39. PubMed ID: 6266317
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid agonist and antagonist bivalent ligands. The relationship between spacer length and selectivity at multiple opioid receptors.
    Portoghese PS; Larson DL; Sayre LM; Yim CB; Ronsisvalle G; Tam SW; Takemori AE
    J Med Chem; 1986 Oct; 29(10):1855-61. PubMed ID: 3020244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists.
    Thomas JB; Mascarella SW; Burgess JP; Xu H; McCullough KB; Rothman RB; Flippen-Anderson JL; George CF; Cantrell BE; Zimmerman DM; Carroll FI
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3149-52. PubMed ID: 9873693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of analogues of acetylmethadol and methadol as potential narcotic antagonists.
    Lattin DL; Caviness B; Hudson RG; Greene DL; Raible PK; Richardson JB
    J Med Chem; 1981 Jul; 24(7):903-6. PubMed ID: 6268789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-alkylnorketobemidones with strong agonist and weak antagonist properties.
    Tokuro O; May EL
    J Med Chem; 1973 Dec; 16(12):1376-8. PubMed ID: 4203140
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activity.
    Natsuka K; Nakamura H; Nishikawa Y; Negoro T; Uno H; Nishimura H
    J Med Chem; 1987 Oct; 30(10):1779-87. PubMed ID: 3656354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.